PegBio Reports No Share Capital Changes in April 2026; Public Float Remains Compliant

Bulletin Express

May 06

PegBio Co., Ltd. (PEGBIO CO-B) released its monthly return for the period ended 30 April 2026, confirming that both registered and issued share capital remained unchanged throughout the month.

The company’s registered share capital stood at 391.09 million shares, comprised of 284.30 million H shares listed in Hong Kong and 106.79 million unlisted domestic shares, each with a par value of RMB 1. No new shares were authorised, issued, cancelled, or repurchased during April.

Issued share capital mirrored the registered figures: 284.30 million listed H shares and 106.79 million unlisted shares, with zero treasury shares on record. PegBio confirmed that its public float satisfied the Main Board’s minimum 25 percent requirement as of month-end.

The filing also noted that no outstanding share options, warrants, convertible securities or other agreements to issue shares were in place. Joint Company Secretary Huang Yifeng submitted the return on 6 May 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1191745791"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1191745791\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1191745791?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-06 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1191745791","market":"hk","top_or_hot":-1,"title":"PegBio Reports No Share Capital Changes in April 2026; Public Float Remains Compliant","media":"Bulletin Express","content":"<p>PegBio Co., Ltd. (PEGBIO CO-B) released its monthly return for the period ended 30 April 2026, confirming that both registered and issued share capital remained unchanged throughout the month.</p>\n<p>The company’s registered share capital stood at 391.09 million shares, comprised of 284.30 million H shares listed in Hong Kong and 106.79 million unlisted domestic shares, each with a par value of RMB 1. No new shares were authorised, issued, cancelled, or repurchased during April.</p>\n<p>Issued share capital mirrored the registered figures: 284.30 million listed H shares and 106.79 million unlisted shares, with zero treasury shares on record. PegBio confirmed that its public float satisfied the Main Board’s minimum 25 percent requirement as of month-end.</p>\n<p>The filing also noted that no outstanding share options, warrants, convertible securities or other agreements to issue shares were in place. Joint Company Secretary Huang Yifeng submitted the return on 6 May 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PegBio Reports No Share Capital Changes in April 2026; Public Float Remains Compliant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPegBio Reports No Share Capital Changes in April 2026; Public Float Remains Compliant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-06 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PegBio Co., Ltd. (PEGBIO CO-B) released its monthly return for the period ended 30 April 2026, confirming that both registered and issued share capital remained unchanged throughout the month.</p>\n<p>The company’s registered share capital stood at 391.09 million shares, comprised of 284.30 million H shares listed in Hong Kong and 106.79 million unlisted domestic shares, each with a par value of RMB 1. No new shares were authorised, issued, cancelled, or repurchased during April.</p>\n<p>Issued share capital mirrored the registered figures: 284.30 million listed H shares and 106.79 million unlisted shares, with zero treasury shares on record. PegBio confirmed that its public float satisfied the Main Board’s minimum 25 percent requirement as of month-end.</p>\n<p>The filing also noted that no outstanding share options, warrants, convertible securities or other agreements to issue shares were in place. Joint Company Secretary Huang Yifeng submitted the return on 6 May 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02565","symbol_name":"派格生物医药-B","start_time":0,"source_url":"","article_id":"1191745791","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1191745791","pubTimestamp":1778058187,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"PegBio Co., Ltd. (PEGBIO CO-B) released its monthly return for the period ended 30 April 2026, confirming that both registered and issued share capital remained unchanged throughout the month. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02565":"派格生物医药-B"},"translate_title":"PegBio报告2026年4月股本没有变化；公众持股量保持合规","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02565":1},"content_text":"PegBio Co., Ltd. (PEGBIO CO-B) released its monthly return for the period ended 30 April 2026, confirming that both registered and issued share capital remained unchanged throughout the month.\nThe company’s registered share capital stood at 391.09 million shares, comprised of 284.30 million H shares listed in Hong Kong and 106.79 million unlisted domestic shares, each with a par value of RMB 1. No new shares were authorised, issued, cancelled, or repurchased during April.\nIssued share capital mirrored the registered figures: 284.30 million listed H shares and 106.79 million unlisted shares, with zero treasury shares on record. PegBio confirmed that its public float satisfied the Main Board’s minimum 25 percent requirement as of month-end.\nThe filing also noted that no outstanding share options, warrants, convertible securities or other agreements to issue shares were in place. Joint Company Secretary Huang Yifeng submitted the return on 6 May 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}